180 related articles for article (PubMed ID: 24761875)
1. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
2. The TP53 intron 6 G13964C polymorphism and risk of thyroid and breast cancer development in the Iranian Azeri population.
Dehghan R; Hosseinpour Feizi MA; Pouladi N; Adampourezare M; Farajzadeh D
Asian Pac J Cancer Prev; 2015; 16(7):3073-7. PubMed ID: 25854408
[TBL] [Abstract][Full Text] [Related]
3. Association of TP53 PIN3 polymorphism with breast cancer in Moroccan population.
Marouf C; Tazzite A; Diakité B; Jouhadi H; Benider A; Nadifi S
Tumour Biol; 2014 Dec; 35(12):12403-8. PubMed ID: 25201062
[TBL] [Abstract][Full Text] [Related]
4. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
Hao W; Xu X; Shi H; Zhang C; Chen X
Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
[TBL] [Abstract][Full Text] [Related]
5. TP53 PIN3 polymorphism associated with breast cancer risk in Iranian women.
Faghani M; Ghasemi FM; Nikhbakht M; Salehi M
Indian J Cancer; 2011; 48(3):298-302. PubMed ID: 21921327
[TBL] [Abstract][Full Text] [Related]
6. Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley.
Malik MA; Sharma K; Goel S; Zargar SA; Mittal B
Oncol Res; 2011; 19(3-4):165-9. PubMed ID: 21473292
[TBL] [Abstract][Full Text] [Related]
7. Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis.
Diakite B; Kassogue Y; Dolo G; Kassogue O; Keita ML; Joyce B; Neuschler E; Wang J; Musa J; Traore CB; Kamate B; Dembele E; Nadifi S; Isichei M; Holl JL; Murphy R; Doumbia S; Hou L; Maiga M
BMC Med Genet; 2020 Jul; 21(1):142. PubMed ID: 32620097
[TBL] [Abstract][Full Text] [Related]
8. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
[TBL] [Abstract][Full Text] [Related]
9. 14-bp Insertion/Deletion Polymorphism of the HLA-G gene in Breast Cancer among Women from North Western Iran.
Haghi M; Hosseinpour Feizi MA; Sadeghizadeh M; Lotfi AS
Asian Pac J Cancer Prev; 2015; 16(14):6155-8. PubMed ID: 26320511
[TBL] [Abstract][Full Text] [Related]
10. Association of rs1219648 in FGFR2 and rs1042522 in TP53 with premenopausal breast cancer in an Iranian Azeri population.
Saadatian Z; Gharesouran J; Ghojazadeh M; Ghohari-Lasaki S; Tarkesh-Esfahani N; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2014; 15(18):7955-8. PubMed ID: 25292094
[TBL] [Abstract][Full Text] [Related]
11. Association of p53 (-16ins-pro) haplotype with the decreased risk of differentiated thyroid carcinoma in Iranian-Azeri patients.
Dehghan R; Hosseinpour Feizi MA; Pouladi N; Babaei E; Montazeri V; Fakhrjoo A; Sedaei A; Azarfam P; Nemati M
Pathol Oncol Res; 2015 Apr; 21(2):449-54. PubMed ID: 25410025
[TBL] [Abstract][Full Text] [Related]
12. TP53 polymorphisms in sporadic North Indian breast cancer patients.
Sharma S; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR; Bansal D; Gupta A
Asian Pac J Cancer Prev; 2014; 15(16):6871-9. PubMed ID: 25169539
[TBL] [Abstract][Full Text] [Related]
13. The intron 3 16 bp duplication polymorphism of p53 (rs17878362) is not associated with increased risk of developing triple-negative breast cancer.
Morten BC; Chiu S; Oldmeadow C; Lubinski J; Scott RJ; Avery-Kiejda KA
Breast Cancer Res Treat; 2019 Feb; 173(3):727-733. PubMed ID: 30430302
[TBL] [Abstract][Full Text] [Related]
14. Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years.
Wang-Gohrke S; Becher H; Kreienberg R; Runnebaum IB; Chang-Claude J
Pharmacogenetics; 2002 Apr; 12(3):269-72. PubMed ID: 11927843
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.
Sagne C; Marcel V; Amadou A; Hainaut P; Olivier M; Hall J
Cell Death Dis; 2013 Feb; 4(2):e492. PubMed ID: 23412385
[TBL] [Abstract][Full Text] [Related]
16. Analysis of TP53 polymorphisms in North Indian sporadic esophageal cancer patients.
Kaur S; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR; Singh G; Singh H
Asian Pac J Cancer Prev; 2014; 15(19):8413-22. PubMed ID: 25339039
[TBL] [Abstract][Full Text] [Related]
17. Single-strand conformational polymorphism analysis of a common single nucleotide variation in WRAP53 gene, rs2287499, and evaluating its association in relation to breast cancer risk and prognosis among Iranian-Azeri population.
Sedaie Bonab A; Pouladi N; Hosseinpourfeizi MA; Ravanbakhsh Gavgani R; Dehghan R; Azarfam P; Montazeri V; Fakhrjou A
Med Oncol; 2014 Sep; 31(9):168. PubMed ID: 25134915
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of p53 gene in Jordanian population and possible associations with breast cancer and lung adenocarcinoma.
Mahasneh AA; Abdel-Hafiz SS
Saudi Med J; 2004 Nov; 25(11):1568-73. PubMed ID: 15573180
[TBL] [Abstract][Full Text] [Related]
19. The TP53 16-bp duplication polymorphism is enriched in endometriosis patients.
Gallegos-Arreola MP; Valencia-Rodríguez LE; Puebla-Pérez AM; Figuera LE; Zúñiga-González GM
Gynecol Obstet Invest; 2012; 73(2):118-23. PubMed ID: 22353881
[TBL] [Abstract][Full Text] [Related]
20. p.R72P, PIN3 Ins16bp polymorphisms of TP53 and CCR5?32 in north Indian breast cancer patients.
Guleria K; Sharma S; Manjari M; Uppal MS; Singh NR; Sambyal V
Asian Pac J Cancer Prev; 2012; 13(7):3305-11. PubMed ID: 22994752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
